Medican Enterprises, Inc. Logo

Medican Enterprises, Inc.

MDCN

(0.0)
Stock Price

0,00 USD

0% ROA

0% ROE

0x PER

Market Cap.

288.140,00 USD

0% DER

0% Yield

0% NPM

Medican Enterprises, Inc. Stock Analysis

Medican Enterprises, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Medican Enterprises, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROA

Unidentified ROA

2 PBV

Unidentified ROA

3 DER

Unidentified DER

4 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

5 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

6 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Graham Number

Unidentified Graham Number

8 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

9 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

10 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

11 ROE

Unidentified ROE

Medican Enterprises, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Medican Enterprises, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Medican Enterprises, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Medican Enterprises, Inc. Revenue
Year Revenue Growth
2000 477.767
2001 483.803 1.25%
2002 349.068 -38.6%
2003 182.127 -91.66%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 624.000 100%
2020 1.104.000 43.48%
2021 4.239.220 73.96%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Medican Enterprises, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Medican Enterprises, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 180.201
2001 200.028 9.91%
2002 104.612 -91.21%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 14.696 100%
2009 6.905 -112.83%
2010 8.636 20.04%
2011 0 0%
2012 9.467 100%
2013 367.042 97.42%
2014 57.536.877 99.36%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Medican Enterprises, Inc. EBITDA
Year EBITDA Growth
2000 -124.988
2001 -62.830 -98.93%
2002 41.320 252.06%
2003 -14.274 389.48%
2004 -73.886 80.68%
2005 -32.564 -126.89%
2006 -6.488 -401.91%
2007 -7.905 17.93%
2008 -14.696 46.21%
2009 -6.905 -112.83%
2010 -8.636 20.04%
2011 -8.035 -7.48%
2012 -9.467 15.13%
2013 -367.042 97.42%
2014 -57.536.877 99.36%
2019 340.580 16993.79%
2020 662.750 48.61%
2021 1.188.230 44.22%
2022 0 0%
2023 0 0%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Medican Enterprises, Inc. Gross Profit
Year Gross Profit Growth
2000 44.687
2001 126.075 64.56%
2002 132.831 5.09%
2003 -9.011 1574.1%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 624.000 100%
2020 214.000 -191.59%
2021 2.030.129 89.46%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Medican Enterprises, Inc. Net Profit
Year Net Profit Growth
2000 -133.979
2001 -83.428 -60.59%
2002 424 19776.42%
2003 -228.641 100.19%
2004 222.655 202.69%
2005 -32.564 783.75%
2006 -6.488 -401.91%
2007 -7.905 17.93%
2008 -14.696 46.21%
2009 -6.905 -112.83%
2010 -8.636 20.04%
2011 -8.035 -7.48%
2012 -18.904 57.5%
2013 -376.449 94.98%
2014 -56.521.453 99.33%
2019 118.421 47829.25%
2020 3.846.915 96.92%
2021 152.653 -2420.04%
2022 0 0%
2023 0 0%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Medican Enterprises, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 0
2001 0 0%
2002 0 0%
2003 -1 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 -14 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Medican Enterprises, Inc. Free Cashflow
Year Free Cashflow Growth
2000 -100.483
2001 -102.245 1.72%
2002 18.146 663.46%
2003 5.483 -230.95%
2004 -240.290 102.28%
2005 -18.750 -1181.55%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 -8.636 100%
2011 -8.035 -7.48%
2012 -9.467 15.13%
2013 -20.079 52.85%
2014 -2.982.189 99.33%
2019 291.080 1124.53%
2020 13.714.982 97.88%
2021 1.213.746 -1029.97%
2022 0 0%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Medican Enterprises, Inc. Operating Cashflow
Year Operating Cashflow Growth
2000 -89.802
2001 -94.765 5.24%
2002 25.048 478.33%
2003 5.483 -356.83%
2004 -240.290 102.28%
2005 -18.750 -1181.55%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 -8.636 100%
2011 -8.035 -7.48%
2012 -9.467 15.13%
2013 -20.079 52.85%
2014 -2.982.189 99.33%
2019 291.080 1124.53%
2020 13.714.982 97.88%
2021 1.213.746 -1029.97%
2022 0 0%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Medican Enterprises, Inc. Capital Expenditure
Year Capital Expenditure Growth
2000 10.681
2001 7.480 -42.79%
2002 6.902 -8.37%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Medican Enterprises, Inc. Equity
Year Equity Growth
2000 -192.290
2001 -266.948 27.97%
2002 -268.407 0.54%
2003 -876.082 69.36%
2004 1.115 78672.38%
2005 -31.449 103.55%
2006 -37.937 17.1%
2007 -45.842 17.24%
2008 -60.538 24.28%
2009 -67.443 10.24%
2010 -76.079 11.35%
2011 -84.114 9.55%
2012 -103.018 18.35%
2013 -296.888 65.3%
2014 -8.302.833 96.42%
2019 6.756.894 222.88%
2020 12.603.809 46.39%
2021 18.082.496 30.3%
2022 0 0%
2023 0 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Medican Enterprises, Inc. Assets
Year Assets Growth
2000 101.936
2001 88.691 -14.93%
2002 79.012 -12.25%
2003 33.913 -132.98%
2004 18.750 -80.87%
2005 0 0%
2006 0 0%
2007 1.200 100%
2008 1.200 0%
2009 1.200 0%
2010 1.200 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 112.624 100%
2019 41.197.951 99.73%
2020 40.479.884 -1.77%
2021 43.508.597 6.96%
2022 0 0%
2023 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Medican Enterprises, Inc. Liabilities
Year Liabilities Growth
2000 294.226
2001 355.639 17.27%
2002 347.419 -2.37%
2003 909.995 61.82%
2004 17.635 -5060.16%
2005 31.449 43.93%
2006 37.937 17.1%
2007 47.042 19.36%
2008 61.738 23.8%
2009 68.643 10.06%
2010 77.279 11.18%
2011 84.114 8.13%
2012 103.018 18.35%
2013 296.888 65.3%
2014 8.415.457 96.47%
2019 34.441.057 75.57%
2020 27.876.075 -23.55%
2021 25.426.101 -9.64%
2022 0 0%
2023 0 0%

Medican Enterprises, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
0x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0
EV to Sales
0
EV Over EBITDA
0
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0
ROE
0
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Medican Enterprises, Inc. Dividends
Year Dividends Growth

Medican Enterprises, Inc. Profile

About Medican Enterprises, Inc.

Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.

CEO
Kelvin Lindsey
Employee
3
Address
3440 East Russell Road
Las Vegas, 89120

Medican Enterprises, Inc. Executives & BODs

Medican Enterprises, Inc. Executives & BODs
# Name Age
1 Mr. Kris Klassen
President
70
2 Kelvin Lindsey
Chief Executive Officer & Director
70

Medican Enterprises, Inc. Competitors